Replies to post #563047 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

If you think that if Advent would NOT get MIA licensed, DCVAXL would somehow get approval anyway you are mistaking The answer is it would not.

Thats a risk no NWBO shareholders counted on which was my post about. Also, the unnecessary risk LP took/is taking here by putting an inexperienced not licensed Advent front and center as a prerequisite for DCVAXL approval.

If you dont see that its because you don't want to. Now Advent will most likely get MIA licensed I was writing about the unnecessary risk LP took/is taking with Advent out of motives of self interest.